Elevated high sensitivity C-reactive protein is associated with type 2 diabetes mellitus: The Persian Gulf healthy heart study

Endocrine Journal

Volumn 55, Issue 4, 2008, Pages 717-722

  Nabipour, Iraj ^a   Vahdat, Katayoun ^a   Jafari, Seyed Mojtaba ^a   Beigi, Saeideh ^a   Assadi, Majid ^a   Azizi, Fatemeh ^a   Sanjdideh, Zahra ^a  

^a BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C reactive protein; Cardiovascular; Diabetes; Inflammation; Obesity

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOMETRY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOKING;

ADULT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IRAN; MALE; RISK FACTORS;

EID: 51449098150     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K08E-026     Document Type: Article

References (32)

1. Pickup JC, Mattock MB, Chusney GD, Burt D (1997) NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40: 1286-1292.
2. Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41: 1241-1248.
3. Festa A, D Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM ( 2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102: 42-47.
4. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19: 972-978.
5. Forouhi NG, Sattar N, McKeigue PM (2001) Relation of C-reative protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes 25: 1324-1328.
6. Komatsu M, Ohfusa H, Aizawa T, Hashizume K (2007) Adiponectin inversely correlates with high sensitive C-reactive protein and triglycerides, but not with insulin sensitivity, in apparently healthy Japanese men. Endocr J 54: 553-558.
7. Dehghan A, Kardys I, de Maat MPM, Uitterlinden AG, Sijbrands EJG, Bootsma AH, Stijnen T, Hofman A, Schram MT, Witteman JCM (2007) Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes 56: 872-878.
8. Jialal I, Devaraj S, Venugopal SK (2004) C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 44: 6-11.
9. Ridker PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107: 363-369.
10. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice/A Statement for Healthcare Professionals. Circulation 107: 499-511.
11. Dondona P, Aljada A, Chaudhuri A, Bandyopadhyay A (2003) The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes. J Clin Endocrinol Metab 88: 2422-2429.
12. Schulze MB, Rimm EB, Li T, Rifai N, Stampfer MJ, Hu FB (2004) C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care 27: 889-894.
13. Vahdat K, Jafari SM, Pazoki R, Nabipour I (2007) Concurrent increased high sensitivity C-reactive protein and chronic infections are associated with coronary artery disease: a population-based study. Indian J Med Sci 61: 135-143.
14. Tan KCB, Wat NMS, Tam SCF, Janus ED, Lam TH, Lam KSL (2003) C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance. Diabetes Care 26: 2323-2328.
15. Doi Y, Kiyohara Y, Kubo M, Ninomiya T, Wakugawa Y, Yonemoto K, Iwase M, Iida M (2005) Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population. Diabetes Care 28: 2497-2500.
16. World Health Organisation (2000) Obesity: preventing and managing the global epidemic: report of a WHO consultation, Geneva. WHO Technical Report Series 894.
17. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care (1997) 20: 1183-1197.
18. Third Report of the Expert Panel on Detection, Evalution, and Treatment of high blood cholesterol in Adults (2004) Adult treatment Panel III. http://www.nhlbi.nih.gov/guidelines/cholesterol.
19. Trayhurn P, Beattie JH (2001) Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60: 329-339.
20. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, Tracy RP(2001) The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health study. Diabetes 50: 2384-2389.
21. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53: 693-700.
22. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N (2002) West of Scotland Coronary Prevention Study: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51: 1596-1600.
23. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286: 327-334.
24. Thorand B, Lowel H, Schneider A, Kolb H, Meisinger C, Frohlich M, Koenig W (2003) C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg Cohort study, 1984-1998. Arch Intern Med 163: 93-99.
25. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM (1996) IRS-1 mediated inhibition of the insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 271: 665-668.
26. Chajek-Shaul T, Friedman G, Stein O, Shiloni E, Etienne J, Stein Y (1989) Mechanism of hypertriglyceridaemia induced by tumour necrosis factor administration to rats. Biochim Biophys Acta 1001: 316-324.
27. Bjorntorp P (1994) Fatty acids, hyperinsulinaemia, and insulin resistance: which comes first? Curr Opin Lipidol 5: 166-174.
28. Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52: 812-817.
29. Cleland SJ, Sattar N, Petrie JR, Forouhi NG, Elliott HL, Connell JM (2000) Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Science 98: 531-535.
30. Tooke J (1999) The association between insulin resistance and endotheliopathy. Diabetes Obes Metab 1(Suppl. 1): S17-S22.
31. Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N (2003) Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care 26: 2754-2757.
32. King DE, Mainous AG 3rd, Buchanan TA, Pearson WS (2003) C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 26: 1535-1539.